ALLO vs CCL · rev $22.0K vs P/E 15, rev $25.02B
Allogene Therapeutics Inc (ALLO) versus Carnival Corporation (CCL) — a side-by-side from cached financials, not a winner call.
Allogene Therapeutics Inc (ALLO) is a biotechnology company listed on US.
Carnival Corporation (CCL) is a travel services company listed on US.
Latest reported ALLO revenue for 2024-12-31 was $22.0K. Net income was -$257.6M. Revenue was down 76.8% from 2023-12-31 to 2024-12-31. ALLO currently screens at market cap $258.1M.
Latest reported CCL revenue for 2024-11-30 was $25.02B. Net income was $1.92B. Revenue was up 15.9% from 2023-11-30 to 2024-11-30. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
ALLO currently screens at market cap $258.1M. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
Not investment advice. Open the ALLO and CCL stock pages for the full models.
Not investment advice.